UroGen Pharma Ltd. (URGN)
NASDAQ: URGN · Real-Time Price · USD
23.45
-0.67 (-2.78%)
Apr 29, 2026, 1:38 PM EDT - Market open
UroGen Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 1,142 | 1,096 | 449 | 463 | 205 | 213 | |
| Market Cap Growth | 144.85% | 143.93% | -2.93% | 126.06% | -3.94% | -46.44% | |
| Enterprise Value | 1,184 | 1,099 | 318 | 409 | 184 | 105 | |
| Last Close Price | 24.12 | 23.42 | 10.65 | 15.00 | 8.87 | 9.51 | |
| PS Ratio | 10.70 | 9.99 | 4.97 | 5.60 | 3.18 | 4.44 | |
| PB Ratio | - | -10.39 | -51.05 | -7.10 | -2.29 | 25.34 | |
| P/TBV Ratio | - | - | - | - | - | 25.34 | |
| EV/Sales Ratio | 10.79 | 10.01 | 3.52 | 4.95 | 2.85 | 2.18 | |
| Debt / Equity Ratio | -1.23 | -1.23 | -14.19 | -1.54 | -1.12 | 0.18 | |
| Net Debt / Equity Ratio | -0.09 | -0.09 | 13.27 | 0.63 | 0.00 | -10.50 | |
| Net Debt / EBITDA Ratio | -0.08 | -0.08 | 1.23 | 0.64 | 0.00 | 0.97 | |
| Net Debt / FCF Ratio | -0.06 | -0.06 | 1.20 | 0.54 | 0.00 | 1.03 | |
| Asset Turnover | 0.45 | 0.45 | 0.39 | 0.53 | 0.50 | 0.40 | |
| Inventory Turnover | 0.97 | 0.97 | 1.19 | 1.87 | 1.67 | 1.52 | |
| Quick Ratio | 3.31 | 3.31 | 5.59 | 4.88 | 4.71 | 4.51 | |
| Current Ratio | 4.01 | 4.01 | 6.01 | 5.42 | 5.39 | 5.11 | |
| Return on Equity (ROE) | - | - | - | - | - | -211.55% | |
| Return on Assets (ROA) | -32.10% | -32.10% | -25.77% | -26.10% | -38.69% | -47.72% | |
| Return on Capital Employed (ROCE) | -81.10% | -81.10% | -39.90% | -44.60% | -70.80% | -94.80% | |
| Earnings Yield | -13.07% | -14.00% | -28.23% | -22.08% | -53.60% | -51.98% | |
| FCF Yield | -13.85% | -14.84% | -21.60% | -16.54% | -42.88% | -40.17% | |
| Buyback Yield / Dilution | -12.22% | -12.22% | -48.70% | -26.43% | -2.05% | -2.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.